BBOT vs SYK · rev $7.5M vs P/E 35, rev $6.59B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
BBOT currently screens at market cap $610.4M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the BBOT and SYK stock pages for the full models.
Not investment advice.